Informa Results Presentation Deck slide image

Informa Results Presentation Deck

gap Accelerating Shareholder Returns Return c50% of post tax proceeds from GAP II Portfolio Focus programme Pharma Intelligence divestment completed for £1.9bn - post-tax proceeds of c.£1.5bn Share Buyback Programme launched on 14 February 2022 ● ● ● £725m Total capital returns now committed Tranche 1 completed: 17m shares repurchased and cancelled at average price of 587p £100m of total value returned to Shareholders by 14 March 2022 Tranche 2 near completion: Further £200m committed to buybacks for a total of £300m c.£290m of total value returned to Shareholders by 15 June 2022 Tranche 3 to follow: ● ● Further £425m committed to buybacks for a total of £725m Expected to be completed by year-end 2022 Ordinary dividend to resume from interim dividend 2022 2022 Annual General Meeting Commitment to Share Buybacks raised to £725m **** informa c.£290m Capital returned to date 575.7p Average share price 50.3m Shares cancelled 15
View entire presentation